Displaying drugs 1301 - 1325 of 2784 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Vilazodone | 441.5249 C26H27N5O2 | An antidepressant agent used for the treatment of major depressive disorder that targets the 5-HT transporter and 5-HT1A receptors. | Agents that produce hypertension | |
Pasireotide | 1047.2062 C58H66N10O9 | A somatostatin analog used in the treatment of Cushing’s disease, specifically for those patients whom pituitary surgery is not appropriate. | Hormones / Somatostatin and Analogues | |
Safinamide | 302.349 C17H19FN2O2 | A MAO-B inhibitor used as an add-on treatment to levodopa/carbidopa for Parkinson's disease during "off" episodes. | Agents that produce hypertension / Agents that reduce seizure threshold | |
Dalfampridine | 94.1145 C5H6N2 | A potassium channel blocker used for the improvement of motor function in patients with multiple sclerosis (MS). | Aminopyridines / Potassium Channel Blockers | |
Isavuconazonium | 717.77 C35H35F2N8O5S | A triazole antifungal used for the treatment of invasive aspergillosis and mucormycosis. | Antifungal Agents / Azole Antifungals | |
Axitinib | 386.47 C22H18N4OS | An oral VEGFR and kinase inhibitor used for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy. | Protein Kinase Inhibitors / Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors | |
Bosutinib | 530.446 C26H29Cl2N5O3 | An antineoplastic agent used for the treatment of chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adults with inadequate clinical response to other treatments. | Bcr-Abl Tyrosine Kinase Inhibitors / Protein Kinase Inhibitors | |
Peramivir | 328.4072 C15H28N4O4 | An intravenous antiviral agent used to treat acute uncomplicated influenza in patients aged 2 years and older who are shown to be symptomatic for no more than two days. | Antiviral Agents / Enzyme Inhibitors / Neuraminidase Inhibitors / Neuraminidase, antagonists & inhibitors | |
Tafenoquine | 463.501 C24H28F3N3O3 | An antiparasitic agent used for the treatment and prevention of relapse of Vivax malaria. | Aminoquinolines | |
Apixaban | 459.4971 C25H25N5O4 | An anticoagulant used for the prophylaxis of stroke and systemic embolism in nonvalvular atrial fibrillation, and deep vein thrombosis(DVT) leading to pulmonary embolism(PE), including in patients after a hip or knee replacement surgery. | Direct factor Xa inhibitors / Factor Xa Inhibitors | |
Panobinostat | 349.434 C21H23N3O2 | A non-selective histone deacetylase inhibitor used to treat multiple myeloma in combination with other antineoplastic agents. | Histone deacetylase (HDAC) inhibitors | |
Midostaurin | 570.649 C35H30N4O4 | An antineoplastic agent used to treat high-risk acute myeloid leukemia (AML) with specific mutations, aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematologic neoplasm (SM-AHN), or mast cell leukemia (MCL). | Protein Kinase Inhibitors | |
Agomelatine | 243.301 C15H17NO2 | Agomelatine is indicated to treat major depressive episodes in adults. | Melatonin, agonists | |
Ceftaroline fosamil | 684.67 C22H21N8O8PS4 | An antibacterial agent used to treat various bacterial infections, such as acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia. | beta Lactam Antibiotics | |
Pazopanib | 437.518 C21H23N7O2S | An antineoplastic agent used in the treatment of advanced renal cell cancer and advanced soft tissue sarcoma in patients with prior chemotherapy. | Protein Kinase Inhibitors | |
Prucalopride | 367.87 C18H26ClN3O3 | A 5-HT4 receptor agonist indicated to treat adults with chronic idiopathic constipation. | Laxatives / Serotonin 5-HT4 Receptor Agonists / Serotonin-4 Receptor Agonist | |
Lonafarnib | 638.822 C27H31Br2ClN4O2 | A potent farnesyl transferase inhibitor used to reduce mortality associated with Hutchinson-Gilford progeria syndrome (HGPS) and other progeroid laminopathies. | Various Alimentary Tract and Metabolism Products | |
Cangrelor | 776.35 C17H25Cl2F3N5O12P3S2 | A P2Y12 platelet receptor antagonist used during percutaneous coronary intervention to reduce the risk for periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST). | Platelet Aggregation Inhibitors Excl. Heparin | |
Tyloxapol | Not Available | Tyloxapol is an inhaled surfactant that assists in removing and liquefying and removing bronchopulmonary secretions with mucus and pus. Tyloxapol is administered either through nebulized solution or a stream of... | Expectorants | |
Calfactant | Not Available | A lung surfactant for the prophylaxis of respiratory distress syndrome in high-risk infants. | Pulmonary Surfactants / Surface-Active Agents | |
Etravirine | 435.277 C20H15BrN6O | A non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV-1 infections in combination with other antiretroviral agents. | Non-Nucleoside Reverse Transcriptase Inhibitors | |
Armodafinil | 273.35 C15H15NO2S | A stimulant used to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea, narcolepsy, or shift work disorder. | Centrally Acting Sympathomimetics | |
Oxymetholone | 332.484 C21H32O3 | An anabolic steroid used for the treatment of types of anemia, such as acquired aplastic anemia, congenital aplastic anemia, myelofibrosis, and the hypoplastic anemias. | Androstan Derivatives | |
Doxercalciferol | 412.6478 C28H44O2 | A synthetic vitamin D2 analog used to treat secondary hyperparathyroidism in patients with chronic kidney disease with or without therapy of dialysis. | Bone Density Conservation Agents / Vitamin D and Analogues / Vitamins | |
Ambrisentan | 378.428 C22H22N2O4 | A selective type A endothelin receptor antagonist used to treat primary pulmonary arterial hypertension and pulmonary arterial hypertension based on diagnostic classifications. | Antihypertensives for Pulmonary Arterial Hypertension |
Displaying drugs 1301 - 1325 of 2784 in total